New COVID variant spreading
A new COVID‑19 variant has been detected and is already spreading across 25 U.S. states, with researchers warning it may partially evade current vaccine protection — a reminder boosters and surveillance remain important. Public‑health agencies are monitoring for vaccine‑escape signals. (independent.co.uk)
The World Health Organization formally listed BA.3.2 as a SARS‑CoV‑2 “Variant Under Monitoring” on December 5, 2025. (who.int) CDC’s MMWR says BA.3.2 was first identified in South Africa on November 22, 2024 and carries roughly 70–75 substitutions and deletions in its spike gene compared with JN.1/LP.8.1 vaccine antigens. (cdc.gov) The first U.S. detection came June 27, 2025 via the CDC Traveler‑Based Genomic Surveillance program in a participant arriving from the Netherlands, and the first clinical specimen in the U.S. was reported January 5, 2026. (cdc.gov) As of February 11, 2026, BA.3.2 had been identified in nasal swabs from four U.S. travelers, clinical samples from five patients, three airplane wastewater samples, and 132 wastewater surveillance samples collected across 25 states, and the lineage had been reported in at least 23 countries. (cdc.gov) Laboratory neutralization data cited by CDC showed the 2025–26 LP.8.1‑adapted mRNA vaccine produced the lowest antibody neutralization against BA.3.2 among seven variants tested, prompting CDC to call for observational studies to assess real‑world effectiveness. (cdc.gov) WHO’s technical evaluation notes BA.3.2 demonstrates antigenic drift and reduced neutralization in vitro but states currently authorized vaccines are still expected to protect against severe disease. (who.int) CDC’s report underscores that detections came from multiple surveillance streams—traveler sampling, clinical sequencing and wastewater monitoring—leading the agency to recommend continued multimodal genomic surveillance to measure BA.3.2’s public‑health impact. (cdc.gov)
